Page 1 of 1

Novel class of compounds for MS and CNS disorders

Posted: Wed Jun 12, 2013 6:22 am
by MSUK
Aphios USA and VivaCell Spain to develop novel class of compounds for MS and CNS disorders

Aphios Corporation, today announced that it has entered into joint Research Collaboration and Commercialisation Agreements with VivaCell Biotechnology EspaƱa S.L., Cordoba, Spain to develop therapeutics for multiple sclerosis and other neurodegenerative diseases of the central nervous system (CNS)......... Read More - http://www.ms-uk.org/index.cfm/cannabisresearch